NET PROFIT (x1000 EUR)
EMPLOYEES
Amplexa Genetics A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-543
|
-407
|
1,337 |
| Total assets |
2,009
|
1,652
|
2,469 |
| Current assets |
1,264
|
1,012
|
1,883 |
| Current liabilities |
267
|
157
|
580 |
| Equity capital |
319
|
-1,949
|
-1,642 |
| - share capital |
2,764
|
81
|
81 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
15.9%
|
-118.0%
|
-66.5% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
473.4%
|
644.6%
|
324.7% |
| Return on equity (ROE) |
-170.2%
|
20.9%
|
-81.4% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.